pediatric asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Inflammation - Pediatric asthma is characterized by chronic inflammation of the airways, leading to swelling and increased mucus production. This inflammatory response is triggered by allergens or irritants, causing the release of inflammatory mediators like histamines and leukotrienes, which narrow the airways and make breathing difficult.

• Secondary mechanism: Hyperresponsiveness - The inflamed airways become hyperresponsive, meaning they overreact to triggers such as exercise, cold air, or respiratory infections. This hyperreactivity results in bronchospasm, where the muscles around the airways constrict further, exacerbating airflow limitation.

• Key complication: Airway remodeling - Over time, persistent inflammation and hyperresponsiveness may lead to structural changes in the airway walls, known as remodeling. This can result in irreversible narrowing of the airways, decreased lung function, and increased severity and frequency of asthma exacerbations.

Patient Profile

Demographics:

8-year-old male, elementary school student

History:

• Key past medical history: Diagnosed with asthma at age 4, history of eczema

• Current medications: Albuterol inhaler as needed, Fluticasone inhaler twice daily

• Allergies: Allergic to dust mites and pollen

Current Presentation:

• Chief complaint: Increased frequency of wheezing and shortness of breath

• Key symptoms: Persistent cough, difficulty breathing, chest tightness, nighttime symptoms, fatigue

• Vital signs: Temperature 98.9°F, Heart rate 110 bpm, Respiratory rate 30 breaths per minute, Oxygen saturation 92% on room air, Blood pressure 105/65 mmHg

Section 1

Change in Patient Status:

A few days after the initial presentation, the patient's symptoms have intensified, leading to a visit to the emergency department. The child now presents with increased work of breathing, evidenced by nasal flaring and intercostal retractions. His respiratory rate has risen to 36 breaths per minute, and his oxygen saturation has decreased to 88% on room air, indicating worsening hypoxemia. The patient appears fatigued, with diminished breath sounds on auscultation and prolonged expiratory wheezing. His heart rate has increased to 120 bpm, suggesting he is compensating for respiratory distress. Despite regular use of his Fluticasone inhaler and frequent use of his Albuterol inhaler, the child continues to experience nocturnal symptoms, suggesting that his asthma is not well-controlled and may have progressed to a more severe state.

The clinical team performs a peak flow measurement, which reveals a significant reduction in the child's peak expiratory flow rate, now at 60% of his personal best. This indicates a severe exacerbation. In response, the team initiates supplemental oxygen therapy to maintain his oxygen saturation above 94%. A repeat chest X-ray is ordered to rule out any secondary complications, such as pneumonia or pneumothorax, that may be contributing to his respiratory distress. Blood tests, including a complete blood count and serum IgE levels, are also conducted to assess for any underlying infections or allergenic triggers that might be exacerbating his asthma. These results will help guide further treatment plans, including potential adjustments to his medication regimen or consideration of additional anti-inflammatory therapies.

This change in status prompts a reassessment of the patient's asthma management plan. The healthcare team considers the possibility of airway remodeling and its impact on his current treatment efficacy. This situation highlights the need for ongoing monitoring and potential escalation of care, including the introduction of a leukotriene receptor antagonist or a trial of oral corticosteroids to rapidly address inflammation. This unfolding scenario stresses the importance of comprehensive asthma education for the family, emphasizing trigger avoidance and the recognition of early warning signs of exacerbation, as well as the need for regular follow-ups with a pediatric pulmonologist.

Section 2

New Diagnostic Results:

Following the child's admission to the emergency department, the results of the chest X-ray are reviewed. The imaging reveals hyperinflation of the lungs, a common finding in asthma exacerbations, but no evidence of pneumonia or pneumothorax, ruling out these complications as the cause of his respiratory distress. The complete blood count shows a mild leukocytosis, indicating a possible inflammatory response, but no significant elevation suggestive of a bacterial infection. The serum IgE levels are notably elevated, reinforcing the suspicion that allergic triggers may be playing a significant role in the child's asthma exacerbation. These findings prompt the healthcare team to focus on identifying specific allergens that might be contributing to the child's symptoms.

In light of the diagnostic results, the clinical team decides to initiate treatment with a leukotriene receptor antagonist to address the allergic component of his asthma. The decision is also made to begin a short course of oral corticosteroids to rapidly reduce airway inflammation, given the severity of his current exacerbation. The child's oxygen saturation improves to 95% with supplemental oxygen, and his respiratory rate decreases to 28 breaths per minute, suggesting a positive response to the initial interventions. However, the healthcare team remains vigilant for potential complications, such as respiratory fatigue or further deterioration.

These developments underscore the necessity for a comprehensive review of the child's asthma action plan, including a detailed assessment of environmental factors at home and school that may need to be modified. The family is provided with education on the importance of adherence to the newly adjusted medication regimen and is encouraged to observe and report any changes in the child's symptoms. A follow-up appointment with a pediatric pulmonologist is scheduled to ensure ongoing management and to discuss possible long-term strategies for preventing future exacerbations. This phase of the child's care emphasizes the importance of a multifaceted approach, integrating pharmacological treatment with lifestyle modifications and regular monitoring to optimize asthma control.

Section 3

A few days after the initial interventions, the child returns for a follow-up visit. During the visit, the nurse conducts a thorough assessment to evaluate the child's current status and response to the treatment plan. Vital signs reveal that the child's respiratory rate has stabilized at 22 breaths per minute, and oxygen saturation is consistently at 97% on room air, indicating a positive response to the oral corticosteroids and leukotriene receptor antagonist. The child reports feeling less breathless during activities, and the parents note a significant reduction in nighttime coughing and wheezing. However, upon auscultation, mild expiratory wheezing is still present, suggesting residual airway constriction.

Despite the improvements, the family shares concerns about the child's recent increase in daytime sleepiness and occasional headaches. These symptoms prompt the healthcare team to consider the potential side effects of the corticosteroids, as well as the need to reassess the child's current medication dosages and schedule. Additionally, the nurse conducts a detailed review of the child's environment, uncovering a potential allergen in the form of a family pet, which had not been previously considered. With the elevated serum IgE levels suggestive of an allergic component, the team discusses the need for allergen testing and potential modifications to the home environment to further reduce exposure.

The nurse emphasizes the importance of maintaining adherence to the asthma action plan and adjusting environmental factors that may contribute to future exacerbations. The healthcare team decides to taper the corticosteroids while continuing the leukotriene receptor antagonist and considers adding a long-term inhaled corticosteroid to the regimen for better control. A referral to an allergist is made to identify specific allergens and devise a targeted strategy for avoidance. As the child's care plan is adjusted, the family is educated on recognizing early signs of exacerbation and the importance of regular follow-ups to monitor the child's progress and prevent complications. This proactive approach aims to enhance the overall quality of life for the child and reduce the risk of future asthma attacks.

Section 4

As the healthcare team continues to monitor the child's progress, a follow-up visit is scheduled two weeks later to evaluate the response to the adjusted treatment plan, which now includes a low-dose inhaled corticosteroid. During this visit, the nurse conducts another comprehensive assessment. The child's vital signs are stable, with a respiratory rate of 20 breaths per minute and oxygen saturation remaining at 98% on room air. The parents report that the child has been experiencing only occasional mild wheezing, predominantly during physical activity, and that nighttime symptoms have almost completely resolved.

However, new diagnostic results from the allergist reveal that the child has a high sensitivity to pet dander and dust mites, which explains the elevated serum IgE levels. These findings prompt a discussion on further environmental control measures. The family is advised to minimize contact with the pet, ensure the child's bedroom is a pet-free zone, and implement measures to reduce dust mite exposure, such as using allergen-proof mattress and pillow covers and regularly cleaning and vacuuming with a HEPA filter.

Despite these interventions, the child begins to exhibit signs of a mild upper respiratory tract infection, characterized by a runny nose and occasional coughing. The healthcare team recognizes the potential for this infection to exacerbate asthma symptoms and decides to maintain a close watch on the child's respiratory status. The nurse educates the family on identifying signs of worsening asthma, reinforcing the importance of adhering to the asthma action plan, and advises on supportive care measures for the cold. This situation necessitates careful management to prevent an escalation of symptoms, highlighting the need for vigilance and adaptability in the child's ongoing treatment strategy.

Section 5

Two days after the follow-up visit, the child presents to the emergency department with increased respiratory distress. The parents report that the mild upper respiratory tract infection seems to have worsened, with the child now experiencing more frequent and severe coughing fits, shortness of breath, and difficulty speaking in full sentences. Upon assessment, the nurse notes that the child appears anxious and is using accessory muscles to breathe. Vital signs reveal a respiratory rate of 30 breaths per minute, heart rate of 120 beats per minute, and oxygen saturation has dropped to 92% on room air. Auscultation of the lungs reveals scattered wheezes and diminished breath sounds in the lower lobes, indicating possible airway obstruction.

Given these findings, the healthcare team suspects that the upper respiratory infection has triggered an acute asthma exacerbation. In response, the child is administered a nebulized bronchodilator to open the airways and supplemental oxygen to maintain adequate oxygenation. The nurse carefully monitors the child's response to the treatment, noting an improvement in breath sounds and a respiratory rate that gradually decreases to 24 breaths per minute. However, the child's heart rate remains elevated, and the nurse educates the parents about the potential side effects of bronchodilator therapy, including increased heart rate and jitteriness.

As the acute episode stabilizes, the healthcare team considers additional investigations to clarify the nature of the exacerbation. A chest X-ray is ordered to rule out other complications such as pneumonia, while blood tests are performed to assess inflammation markers and further evaluate the immune response. The team also reviews the child's asthma action plan with the parents, emphasizing adjustments necessary to address the current exacerbation and prevent future episodes. This moment underscores the importance of dynamic care planning and vigilant monitoring in managing pediatric asthma, particularly in the face of complicating factors like infections.